论文信息 - Targeting MYC through WDR5

Targeting MYC through WDR5

ABSTRACT The oncoprotein transcription factor MYC is overexpressed in most cancers and is responsible for hundreds of thousands of cancer deaths worldwide every year. MYC is also a highly validated – but currently undruggable – anti-cancer target. We recently showed that breaking the interaction of MYC with its chromatin co-factor WD repeat-containing protein 5 (WDR5) promotes tumor regression in mouse xenografts, laying the foundation for a new strategy to inhibit MYC in the clinic.

[1] S. Fesik,et al. Interaction of the oncoprotein transcription factor MYC with its chromatin cofactor WDR5 is essential for tumor maintenance , 2019, Proceedings of the National Academy of Sciences.

[2] S. Fesik,et al. Discovery and Optimization of Salicylic Acid-Derived Sulfonamide Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)-MYC Protein-Protein Interaction. , 2019, Journal of medicinal chemistry.

[3] M. Guenther,et al. Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy , 2019, Science Translational Medicine.

[4] S. Fesik,et al. Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity , 2019, Cell reports.

[5] G. Qing,et al. Targeting oncogenic Myc as a strategy for cancer treatment , 2018, Signal Transduction and Targeted Therapy.

[6] W. Tansey,et al. Moonlighting with WDR5: A Cellular Multitasker , 2018, Journal of clinical medicine.

[7] Qi Sun,et al. Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC. , 2015, Molecular cell.

[8] D. Felsher,et al. MYC activation is a hallmark of cancer initiation and maintenance. , 2014, Cold Spring Harbor perspectives in medicine.

[9] W. Tansey. Mammalian MYC Proteins and Cancer , 2014 .

[10] G. Evan,et al. Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice. , 2013, Genes & development.